BIOGEN INC. Interest Expense
BIOGEN INC. (BIIB) reported Interest Expense of $67.60 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2026-04-29
- BIOGEN INC. interest expense for the quarter ending 2026-03-31 was $67.60M, a 12.67% increase year-over-year.
- BIOGEN INC. interest expense for the quarter ending 2025-12-31 was $67.50M, a 12.50% increase year-over-year.
- BIOGEN INC. interest expense for the quarter ending 2025-09-30 was $67.40M, a 12.71% increase year-over-year.
- BIOGEN INC. interest expense for the quarter ending 2025-06-30 was $72.60M, a 18.43% increase year-over-year.
- BIOGEN INC. interest expense for fiscal 2025 was $267.50M, a 6.87% increase from fiscal 2024.
- BIOGEN INC. interest expense for fiscal 2024 was $250.30M, a 1.38% increase from fiscal 2023.
- BIOGEN INC. interest expense for fiscal 2023 was $246.90M, a 0.12% increase from fiscal 2022.
- BIOGEN INC. interest expense for fiscal 2022 was $246.60M, a 2.76% decline from fiscal 2021.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2026-03-31 | $67.60M 10-Q · filed 2026-04-29 | $135.10M derived: sum of 2 quarters · filed 2026-04-29 | $202.50M derived: sum of 3 quarters · filed 2026-04-29 | $275.10M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-12-31 | $67.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $134.90M derived: sum of 2 quarters · filed 2026-02-06 | $207.50M derived: sum of 3 quarters · filed 2026-02-06 | $267.50M 10-K · filed 2026-02-06 |
| 2025-09-30 | $67.40M 10-Q · filed 2025-10-30 | $140.00M derived: sum of 2 quarters · filed 2025-10-30 | $200.00M 10-Q · filed 2025-10-30 | $260.00M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-06-30 | $72.60M 10-Q · filed 2025-07-31 | $132.60M 10-Q · filed 2025-07-31 | $192.60M derived: sum of 3 quarters · filed 2026-04-29 | $252.40M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-03-31 | $60.00M 10-Q · filed 2026-04-29 | $120.00M derived: sum of 2 quarters · filed 2026-04-29 | $179.80M derived: sum of 3 quarters · filed 2026-04-29 | $241.10M derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | $60.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $119.80M derived: sum of 2 quarters · filed 2026-02-06 | $181.10M derived: sum of 3 quarters · filed 2026-02-06 | $250.30M 10-K · filed 2026-02-06 |
| 2024-09-30 | $59.80M 10-Q · filed 2025-10-30 | $121.10M derived: sum of 2 quarters · filed 2025-10-30 | $190.30M 10-Q · filed 2025-10-30 | $261.80M derived: sum of 4 quarters · filed 2026-02-06 |
| 2024-06-30 | $61.30M 10-Q · filed 2025-07-31 | $130.50M 10-Q · filed 2025-07-31 | $202.00M derived: sum of 3 quarters · filed 2026-02-06 | $265.80M derived: sum of 4 quarters · filed 2026-02-06 |
| 2024-03-31 | $69.20M 10-Q · filed 2025-05-01 | $140.70M derived: sum of 2 quarters · filed 2026-02-06 | $204.50M derived: sum of 3 quarters · filed 2026-02-06 | $253.60M derived: sum of 4 quarters · filed 2026-02-06 |
| 2023-12-31 | $71.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $135.30M derived: sum of 2 quarters · filed 2026-02-06 | $184.40M derived: sum of 3 quarters · filed 2026-02-06 | $246.90M 10-K · filed 2026-02-06 |
| 2023-09-30 | $63.80M 10-Q · filed 2024-10-30 | $112.90M derived: sum of 2 quarters · filed 2024-10-30 | $175.40M 10-Q · filed 2024-10-30 | $230.20M derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-06-30 | $49.10M 10-Q · filed 2024-08-01 | $111.60M 10-Q · filed 2024-08-01 | $166.40M derived: sum of 3 quarters · filed 2025-02-12 | $226.30M derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-03-31 | $62.50M 10-Q · filed 2024-04-24 | $117.30M derived: sum of 2 quarters · filed 2025-02-12 | $177.20M derived: sum of 3 quarters · filed 2025-02-12 | $243.00M derived: sum of 4 quarters · filed 2025-02-12 |
| 2022-12-31 | $54.80M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | $114.70M derived: sum of 2 quarters · filed 2025-02-12 | $180.50M derived: sum of 3 quarters · filed 2025-02-12 | $246.60M 10-K · filed 2025-02-12 |
| 2022-09-30 | $59.90M 10-Q · filed 2023-11-08 | $125.70M derived: sum of 2 quarters · filed 2023-11-08 | $191.80M 10-Q · filed 2023-11-08 | $258.10M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-06-30 | $65.80M 10-Q · filed 2023-07-25 | $131.90M 10-Q · filed 2023-07-25 | $198.20M derived: sum of 3 quarters · filed 2024-02-14 | $264.50M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-03-31 | $66.10M 10-Q · filed 2023-04-25 | $132.40M derived: sum of 2 quarters · filed 2024-02-14 | $198.70M derived: sum of 3 quarters · filed 2024-02-14 | $255.10M derived: sum of 4 quarters · filed 2024-02-14 |
| 2021-12-31 | $66.30M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $132.60M derived: sum of 2 quarters · filed 2024-02-14 | $189.00M derived: sum of 3 quarters · filed 2024-02-14 | $253.60M 10-K · filed 2024-02-14 |
| 2021-09-30 | $66.30M 10-Q · filed 2022-10-25 | $122.70M derived: sum of 2 quarters · filed 2022-10-25 | $187.30M 10-Q · filed 2022-10-25 | $243.40M derived: sum of 4 quarters · filed 2023-02-15 |
| 2021-06-30 | $56.40M 10-Q · filed 2022-07-20 | $121.10M 10-Q · filed 2022-07-20 | $177.10M derived: sum of 3 quarters · filed 2023-02-15 | $233.40M derived: sum of 4 quarters · filed 2023-02-15 |
| 2021-03-31 | $64.70M 10-Q · filed 2022-05-03 | $120.70M derived: sum of 2 quarters · filed 2023-02-15 | $177.00M derived: sum of 3 quarters · filed 2023-02-15 | $243.00M derived: sum of 4 quarters · filed 2023-02-15 |
| 2020-12-31 | $56.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15 | $112.30M derived: sum of 2 quarters · filed 2023-02-15 | $178.30M derived: sum of 3 quarters · filed 2023-02-15 | $222.50M 10-K · filed 2023-02-15 |
| 2020-09-30 | $56.30M 10-Q · filed 2021-10-20 | $122.30M derived: sum of 2 quarters · filed 2021-10-20 | $166.50M 10-Q · filed 2021-10-20 | $212.60M derived: sum of 4 quarters · filed 2022-02-03 |
| 2020-06-30 | $66.00M 10-Q · filed 2021-07-22 | $110.30M 10-Q · filed 2021-07-22 | $156.30M derived: sum of 3 quarters · filed 2022-02-03 | $202.10M derived: sum of 4 quarters · filed 2022-02-03 |
| 2020-03-31 | $44.30M 10-Q · filed 2021-04-22 | $90.30M derived: sum of 2 quarters · filed 2022-02-03 | $136.10M derived: sum of 3 quarters · filed 2022-02-03 | $183.80M derived: sum of 4 quarters · filed 2022-02-03 |
| 2019-12-31 | $46.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-03 | $91.80M derived: sum of 2 quarters · filed 2022-02-03 | $139.50M derived: sum of 3 quarters · filed 2022-02-03 | $187.40M 10-K · filed 2022-02-03 |
| 2019-09-30 | $45.80M 10-Q · filed 2020-10-21 | $93.50M derived: sum of 2 quarters · filed 2020-10-21 | $141.40M 10-Q · filed 2020-10-21 | $190.80M derived: sum of 4 quarters · filed 2021-02-03 |
| 2019-06-30 | $47.70M 10-Q · filed 2020-07-22 | $95.60M 10-Q · filed 2020-07-22 | $145.00M derived: sum of 3 quarters · filed 2021-02-03 | $194.00M derived: sum of 4 quarters · filed 2021-02-03 |
| 2019-03-31 | $47.90M 10-Q · filed 2020-04-23 | $97.30M derived: sum of 2 quarters · filed 2021-02-03 | $146.30M derived: sum of 3 quarters · filed 2021-02-03 | $198.00M derived: sum of 4 quarters · filed 2021-02-03 |
| 2018-12-31 | $49.40M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-03 | $98.40M derived: sum of 2 quarters · filed 2021-02-03 | $150.10M derived: sum of 3 quarters · filed 2021-02-03 | $200.60M 10-K · filed 2021-02-03 |
| 2018-09-30 | $49.00M 10-Q · filed 2019-10-22 | $100.70M derived: sum of 2 quarters · filed 2019-10-22 | $151.20M 10-Q · filed 2019-10-22 | $213.20M derived: sum of 4 quarters · filed 2020-02-06 |
| 2018-06-30 | $51.70M 10-Q · filed 2019-07-24 | $102.20M 10-Q · filed 2019-07-24 | $164.20M derived: sum of 3 quarters · filed 2020-02-06 | $226.00M derived: sum of 4 quarters · filed 2020-02-06 |
| 2018-03-31 | $50.50M 10-Q · filed 2019-04-24 | $112.50M derived: sum of 2 quarters · filed 2020-02-06 | $174.30M derived: sum of 3 quarters · filed 2020-02-06 | $237.90M derived: sum of 4 quarters · filed 2020-02-06 |
| 2017-12-31 | $62.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-06 | $123.80M derived: sum of 2 quarters · filed 2020-02-06 | $187.40M derived: sum of 3 quarters · filed 2020-02-06 | $250.80M 10-K · filed 2020-02-06 |
| 2017-09-30 | $61.80M 10-Q · filed 2018-10-23 | $125.40M derived: sum of 2 quarters · filed 2018-10-23 | $188.80M 10-Q · filed 2018-10-23 | $253.60M derived: sum of 4 quarters · filed 2019-02-06 |
| 2017-06-30 | $63.60M 10-Q · filed 2018-07-24 | $127.00M 10-Q · filed 2018-07-24 | $191.80M derived: sum of 3 quarters · filed 2019-02-06 | $257.80M derived: sum of 4 quarters · filed 2019-02-06 |
| 2017-03-31 | $63.40M 10-Q · filed 2018-04-24 | $128.20M derived: sum of 2 quarters · filed 2019-02-06 | $194.20M derived: sum of 3 quarters · filed 2019-02-06 | $260.10M derived: sum of 4 quarters · filed 2019-02-06 |
| 2016-12-31 | $64.80M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-06 | $130.80M derived: sum of 2 quarters · filed 2019-02-06 | $196.70M derived: sum of 3 quarters · filed 2019-02-06 | $260.00M 10-K · filed 2019-02-06 |
| 2016-09-30 | $66.00M 10-Q · filed 2017-10-24 | $131.90M derived: sum of 2 quarters · filed 2017-10-24 | $195.20M 10-Q · filed 2017-10-24 | $262.60M derived: sum of 4 quarters · filed 2018-02-01 |
| 2016-06-30 | $65.90M 10-Q · filed 2017-07-25 | $129.20M 10-Q · filed 2017-07-25 | $196.60M derived: sum of 3 quarters · filed 2018-02-01 | $212.20M derived: sum of 4 quarters · filed 2018-02-01 |
| 2016-03-31 | $63.30M 10-Q · filed 2017-04-25 | $130.70M derived: sum of 2 quarters · filed 2018-02-01 | $146.30M derived: sum of 3 quarters · filed 2018-02-01 | $152.10M derived: sum of 4 quarters · filed 2018-02-01 |
| 2015-12-31 | $67.40M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-01 | $83.00M derived: sum of 2 quarters · filed 2018-02-01 | $88.80M derived: sum of 3 quarters · filed 2018-02-01 | $95.50M 10-K · filed 2018-02-01 |
| 2015-09-30 | $15.60M 10-Q · filed 2016-10-26 | $21.40M derived: sum of 2 quarters · filed 2016-10-26 | $28.10M 10-Q · filed 2016-10-26 | $35.50M derived: sum of 4 quarters · filed 2017-02-02 |
| 2015-06-30 | $5.80M 10-Q · filed 2016-07-21 | $12.50M 10-Q · filed 2016-07-21 | $19.90M derived: sum of 3 quarters · filed 2017-02-02 | $27.30M derived: sum of 4 quarters · filed 2017-02-02 |
| 2015-03-31 | $6.70M 10-Q · filed 2016-04-21 | $14.10M derived: sum of 2 quarters · filed 2017-02-02 | $21.50M derived: sum of 3 quarters · filed 2017-02-02 | $28.60M derived: sum of 4 quarters · filed 2017-02-02 |
| 2014-12-31 | $7.40M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-02 | $14.80M derived: sum of 2 quarters · filed 2017-02-02 | $21.90M derived: sum of 3 quarters · filed 2017-02-02 | $29.50M 10-K · filed 2017-02-02 |
| 2014-09-30 | $7.40M 10-Q · filed 2015-10-21 | $14.50M derived: sum of 2 quarters · filed 2015-10-21 | $22.10M 10-Q · filed 2015-10-21 | $28.50M derived: sum of 4 quarters · filed 2016-02-03 |
| 2014-06-30 | $7.10M 10-Q · filed 2015-07-24 | $14.70M 10-Q · filed 2015-07-24 | $21.10M derived: sum of 3 quarters · filed 2016-02-03 | $27.70M derived: sum of 4 quarters · filed 2016-02-03 |
| 2014-03-31 | $7.60M 10-Q · filed 2015-04-24 | $14.00M derived: sum of 2 quarters · filed 2016-02-03 | $20.60M derived: sum of 3 quarters · filed 2016-02-03 | $27.90M derived: sum of 4 quarters · filed 2016-02-03 |
| 2013-12-31 | $6.40M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-03 | $13.00M derived: sum of 2 quarters · filed 2016-02-03 | $20.30M derived: sum of 3 quarters · filed 2016-02-03 | $31.90M 10-K · filed 2016-02-03 |
| 2013-09-30 | $6.60M 10-Q · filed 2014-10-22 | $13.90M derived: sum of 2 quarters · filed 2014-10-22 | $25.50M 10-Q · filed 2014-10-22 | $38.80M derived: sum of 4 quarters · filed 2015-02-04 |
| 2013-06-30 | $7.30M 10-Q · filed 2014-07-23 | $18.90M 10-Q · filed 2014-07-23 | $32.20M derived: sum of 3 quarters · filed 2015-02-04 | $40.90M derived: sum of 4 quarters · filed 2015-02-04 |
| 2013-03-31 | $11.50M 10-Q · filed 2014-04-23 | $24.90M derived: sum of 2 quarters · filed 2015-02-04 | $33.60M derived: sum of 3 quarters · filed 2015-02-04 | $40.60M derived: sum of 4 quarters · filed 2015-02-04 |
| 2012-12-31 | $13.40M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-04 | $22.10M derived: sum of 2 quarters · filed 2015-02-04 | $29.10M derived: sum of 3 quarters · filed 2015-02-04 | $36.50M 10-K · filed 2015-02-04 |
| 2012-09-30 | $8.70M 10-Q · filed 2013-10-28 | $15.70M derived: sum of 2 quarters · filed 2013-10-28 | $23.10M 10-Q · filed 2013-10-28 | $30.60M derived: sum of 4 quarters · filed 2014-02-06 |
| 2012-06-30 | $7.00M 10-Q · filed 2013-07-25 | $14.40M 10-Q · filed 2013-07-25 | $21.90M derived: sum of 3 quarters · filed 2014-02-06 | $29.80M derived: sum of 4 quarters · filed 2014-02-06 |
| 2012-03-31 | $7.40M 10-Q · filed 2013-04-25 | $14.90M derived: sum of 2 quarters · filed 2014-02-06 | $22.80M derived: sum of 3 quarters · filed 2014-02-06 | $31.20M derived: sum of 4 quarters · filed 2014-02-06 |
| 2011-12-31 | $7.50M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-06 | $15.40M derived: sum of 2 quarters · filed 2014-02-06 | $23.80M derived: sum of 3 quarters · filed 2014-02-06 | $33.00M 10-K · filed 2014-02-06 |
| 2011-09-30 | $7.90M 10-Q · filed 2012-10-25 | $16.30M derived: sum of 2 quarters · filed 2012-10-25 | $25.50M 10-Q · filed 2012-10-25 | $35.00M derived: sum of 4 quarters · filed 2013-02-05 |
| 2011-06-30 | $8.40M 10-Q · filed 2012-07-24 | $17.60M 10-Q · filed 2012-07-24 | $27.10M derived: sum of 3 quarters · filed 2013-02-05 | $36.40M derived: sum of 4 quarters · filed 2013-02-05 |
| 2011-03-31 | $9.20M 10-Q · filed 2012-05-01 | $18.70M derived: sum of 2 quarters · filed 2013-02-05 | $28.00M derived: sum of 3 quarters · filed 2013-02-05 | $37.00M derived: sum of 4 quarters · filed 2013-02-05 |
| 2010-12-31 | $9.50M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-05 | $18.80M derived: sum of 2 quarters · filed 2013-02-05 | $27.80M derived: sum of 3 quarters · filed 2013-02-05 | $36.10M 10-K · filed 2013-02-05 |
| 2010-09-30 | $9.30M 10-Q · filed 2011-10-28 | $18.30M derived: sum of 2 quarters · filed 2011-10-28 | $26.60M 10-Q · filed 2011-10-28 | $34.80M derived: sum of 4 quarters · filed 2012-02-03 |
| 2010-06-30 | $9.00M 10-Q · filed 2011-07-26 | $17.30M 10-Q · filed 2011-07-26 | $25.50M derived: sum of 3 quarters · filed 2012-02-03 | $34.00M derived: sum of 4 quarters · filed 2012-02-03 |
| 2010-03-31 | $8.30M 10-Q · filed 2011-04-21 | $16.50M derived: sum of 2 quarters · filed 2012-02-03 | $25.00M derived: sum of 3 quarters · filed 2012-02-03 | $34.30M derived: sum of 4 quarters · filed 2012-02-03 |
| 2009-12-31 | $8.20M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-03 | $16.70M derived: sum of 2 quarters · filed 2012-02-03 | $26.00M derived: sum of 3 quarters · filed 2012-02-03 | $35.80M 10-K · filed 2012-02-03 |
| 2009-09-30 | $8.50M 10-Q · filed 2010-10-26 | $17.80M derived: sum of 2 quarters · filed 2010-10-26 | $27.60M 10-Q · filed 2010-10-26 | |
| 2009-06-30 | $9.30M 10-Q · filed 2010-07-20 | $19.20M 10-Q · filed 2010-07-20 | ||
| 2008-12-31 | $52.00M 10-K · filed 2011-02-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |